Schedule 13D ownership disclosure

BIOXCEL THERAPEUTICS INC

Security class unavailable · CUSIP: 09075P105

Event date: 2024-06-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
20.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-069194
Form type
SC 13D/A
Filer
BioXcel LLC
CIK
CIK 1651990
Filed
Jun 06, 2024
Reporting period
Jun 06, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub